PDE5A and erectile dysfunction: Potent and selective PDE5 inhibitors have been approved for therapeutic use for the condition of erectile dysfunction [11] and are currently also being used in the treatment of pulmonary hypertension [12, 13] and Raynaud’s phenomenon [14].